IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 297 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,193,940 | -45.9% | 897,000 | 0.0% | 1.64% | -43.3% |
| Q1 2024 | $13,293,540 | +82.3% | 897,000 | 0.0% | 2.90% | +49.4% |
| Q4 2023 | $7,292,610 | +162.7% | 897,000 | +47.0% | 1.94% | +114.7% |
| Q3 2023 | $2,775,500 | -6.4% | 610,000 | +44.9% | 0.90% | +27.4% |
| Q2 2023 | $2,963,840 | +15.2% | 421,000 | 0.0% | 0.71% | -7.9% |
| Q1 2023 | $2,572,310 | -29.6% | 421,000 | +29.5% | 0.77% | -17.2% |
| Q3 2018 | $3,656,000 | – | 325,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 19,997,103 | $90,986,819 | 11.15% |
| MPM BioImpact LLC | 3,287,397 | $14,957,656 | 3.99% |
| Perceptive Advisors | 11,962,938 | $54,431,367 | 1.82% |
| CM Management, LLC | 200,000 | $910,000 | 0.97% |
| Velan Capital Investment Management LP | 250,000 | $1,137,500 | 0.92% |
| Opaleye Management Inc. | 610,000 | $2,775,500 | 0.90% |
| Boxer Capital, LLC | 3,705,133 | $16,858,355 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 985,000 | $4,481,750 | 0.87% |
| Parametrica Management Ltd | 95,400 | $434,070 | 0.73% |
| 683 Capital Management, LLC | 2,050,000 | $9,327,501 | 0.72% |